Varian Medical Systems VAR will showcase the company's full spectrum of prostate cancer treatment technologies at the upcoming American Urological Association Meeting in Washington, D.C. During the meeting, Varian will sponsor a series of presentations covering emerging treatments and multi-disciplinary approaches to prostate cancer care.
Within the company's exhibit, Varian will showcase its latest solutions for high- and low-dose-rate brachytherapy, intensity-modulated radiotherapy, and stereotactic body radiotherapy, an emerging and promising new approach that involves delivering higher doses to the prostate over a shorter time period than would be the case with conventional radiotherapy.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in